7Burtelow M,Riley E,Druzin M,et al. How we treat: management of life-threatening primary postpartun hemorrhage with a standard- iaed massive transfusion protocol [J].Transfusion,2007A7:1564- 1572.
二级参考文献10
1.Zhang Ling-mei,DingHui.(BeiJing Municipal Institute for Women HealthCare , 100006.).全国孕产妇死亡监测结果分析[J].中华妇产科杂志,1994,29(9):514-517. 被引量：197
5Unningham FG. Williams Obstercs [M]. 22nd. Jinan : Scientific and Technical Publishing Company, 2006:561.
6Ceminski A, Dlugolecki F. Relationship between placenta prevail and matemal age, parity and caesarean deliveries [J]. Ginekol Pol, 2005, 76 (4): 285.
7Bone R C , Balk R A , Cerra F B , et al . Definitions for sepsis and organ failure and guidelines for t he use of innovative therapies in sepsis. Chest ,1992,101 (6) :1644.
3Westover AJ,Moss TJ. Effects of intrauterine infection orinflammation on fetal lung development [ J ]. Clin ExpePharmacol Physiol,2012,39(9) :824-830.
4Zhang F, Xing J,Liou AK,et al. Enhanced delivery oferythropoietin across the Blood-Brain barrier for neuro-protection against ischemic neuronal injury [ J ]. TranslStroke Res,2010,l⑵:113-121.
5Klinger G.Sokolover N,Boyko V,et al. Perinatal risk fac-tors for bronchopulmonary dysplasia in a National cohortof very-low-birthweight infants [J]. Am J Obstet Gyne-col,2013,208(2) : ell0-115.
6Karar J, Maity A. PI3K/AKT/mTOR pathway in angio-genesis[J]. Front Mol Neurosci,2011,4(51) :51.
7Rayjada N,Barton L,Chan LS,et al. Decrease in incidenceof bronchopulmonary dysplasia with erythropoietin ad-ministration in preterm infants:a retrospective study[J].Neonatology, 2012,102(4) :287-292.
